Author:
Norzaee Samira,Yunesian Masud,Ghorbanian Arsalan,Farzadkia Mahdi,Rezaei Kalantary Roshanak,Kermani Majid,Nourbakhsh Seyed Mohammad-Kazem,Eghbali Aziz
Abstract
AbstractWe conducted a hospital-based case–control study to explore the association between proximity to various land use types and childhood leukemia and lymphoma. This research involved 428 cases of childhood leukemia and lymphoma (2016–2021), along with a control group of 428 children aged 1–15 in Tehran. We analyzed the risk of childhood cancer associated with land use by employing logistic regression adjusted for confounding factors such as parental smoking and family history. The odds ratio (OR) for children with leukemia and lymphoma residing within 100 m of the nearest highway was 1.87 (95% CI = 1.00–3.49) and 1.71 (95% CI = 1.00–2.93), respectively, in comparison to those living at a distance of 1000 m or more from a highway. The OR for leukemia with exposure to petrol stations within 100 m was 2.15 (95% CI = 1.00–4.63), and for lymphoma it was 1.09 (95% CI = 0.47–2.50). A significant association was observed near power lines (OR = 3.05; 95% CI = 0.97–9.55) within < 100 m for leukemia. However, no significant association was observed between power lines and the incidence of childhood lymphoma. There was no association between bus stations, major road class 2, and the incidence of childhood leukemia and lymphoma. In conclusion, our results suggest a possible association between the incidence of childhood leukemia and proximity to different urban land uses (i.e., highways and petrol stations). This study is the first step in understanding how urban land use affects childhood leukemia and lymphoma in Tehran. However, comprehensive studies considering individual-level data and specific pollutants are essential for a more nuanced understanding of these associations.
Publisher
Springer Science and Business Media LLC
Reference75 articles.
1. Johnston, W. T. et al. Childhood cancer: Estimating regional and global incidence. Cancer Epidemiol. 71, 101662. https://doi.org/10.1016/j.canep.2019.101662 (2021).
2. Wilson, C. L. et al. Trends in physical functioning in acute lymphoblastic leukemia and non-Hodgkin lymphoma survivors across three decades. J. Cancer Surviv. https://doi.org/10.1007/s11764-023-01483-1 (2023).
3. Taj, T. et al. Exposure to PM2.5 constituents and risk of adult leukemia in Denmark: A population-based case–control study. Environ. Res. 196, 110418 (2021).
4. Singh, R. et al. Non-Hodgkin’s lymphoma: A review. J. Fam. Med. Prim. Care 9, 1834–1840. https://doi.org/10.4103/jfmpc.jfmpc_1037_19 (2020).
5. Keykhosravi, A., Neamatshahi, M., Navipour, E., Barabadi, Z. & Neamatshahi, M. Incidence prevalence and associated risk factors for leukemia and lyphoma occurrence in Iran: A systematic review and meta analysis. Int. J. Med. Rev. 8, 57–64 (2021).